SCIENTURE HOLDINGS, INC. Equity Method Investment, Ownership Percentage
SCIENTURE HOLDINGS, INC. (SCNX) had Equity Method Investment, Ownership Percentage of 100.00% as of 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-05-09
- 2022-03-31: Equity Method Investment, Ownership Percentage 100.00%.
- 2021-12-31: Equity Method Investment, Ownership Percentage 100.00%.
- 2021-09-30: Equity Method Investment, Ownership Percentage 100.00%.
- 2021-06-30: Equity Method Investment, Ownership Percentage 100.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2022-03-31 | 100.00% 10-Q · filed 2022-05-09 |
| 2021-12-31 | 100.00% 10-K · filed 2022-03-28 |
| 2021-09-30 | 100.00% 10-Q · filed 2021-10-25 |
| 2021-06-30 | 100.00% 10-Q · filed 2021-07-26 |
| 2021-03-31 | 100.00% 10-Q · filed 2021-04-26 |
| 2020-12-31 | 100.00% 10-K · filed 2021-03-29 |
| 2020-09-30 | 100.00% 10-Q · filed 2020-10-26 |
| 2020-06-30 | 100.00% 10-Q · filed 2020-07-27 |
| 2020-03-31 | 100.00% 10-Q · filed 2020-05-04 |
| 2019-12-31 | 100.00% 10-K · filed 2020-03-30 |
| 2019-09-30 | 100.00% 10-Q · filed 2019-10-28 |
| 2019-06-30 | 100.00% 10-Q · filed 2019-07-26 |
| 2019-03-31 | 100.00% 10-Q · filed 2019-05-13 |
| 2018-12-31 | 100.00% 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |